Carl Zeiss Meditec AG (ETR:AFX) shareholders are probably feeling a little disappointed, since its shares fell 7.0% to €43.04 in the week after its latest third-quarter results. It looks like a pretty ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Hello, ladies and gentlemen, and welcome to the Carl Zeiss Meditec AG Analyst Conference for the Six Months 2025 Results. At this time, all participants have been placed on a listen-only mode. The ...
Shareholders might have noticed that Carl Zeiss Meditec AG (ETR:AFX) filed its annual result this time last week. The early response was not positive, with shares down 6.6% to €40.58 in the past week.
Good morning, ladies and gentlemen, and welcome to the Carl Zeiss Meditec follow-up call regarding the CEO change announcement. [Operator Instructions] Let me now turn the floor over to your host, ...
Acquisition will extend the company's leadership in ophthalmic medical devices market and expands its position in the vitreo-retinal surgery segment D.O.R.C., a leading player in the retinal surgical ...
When it comes to camera optics and lenses, one of the biggest names in the industry is Carl Zeiss. The company has announced that it will be entering into the micro four thirds market with Olympus.
ZEISS Medical Technology will showcase new ophthalmic innovations and market milestones at ESCRS from Sept. 12 - 15 in Copenhagen, Denmark: EFFICIENT, CONFIDENT DECISION MAKING: introducing AI-powered ...
Fully integrated AI decision support tool flags B scans that may require further review, supporting more confident decision making and more efficient patient care. JENA, Germany, Aug. 21, 2025 ...
You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Apple has partnered with the German lens and optics manufacturer Carl Zeiss AG on a new pair of ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.